# Robigo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/robigo

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.robigo.bio
- Total disclosed funding: $13M
- Latest round: Series A (Sep 17, 2026)
- Investors on record: 9

## About

Founded in 2021, Robigo, Inc. is a US-based company dedicated to developing innovative microbial solutions that enhance crop protection and promote environmental sustainability, targeting agricultural producers across key global markets.Robigo, Inc. specializes in engineered microbial solutions for agriculture. Founded by Andee Wallace (CEO), the company is headquartered in Cambridge, US. In September 2026, Robigo, Inc. raised series A funding led by Leaps by Bayer, with participation from Illumina Ventures, Thrive,Congruent Ventures and Endeavor8.

Robigo focuses on developing innovative microbial solutions aimed at enhancing crop protection while promoting environmental sustainability. The company's main offerings include a range of engineered microbes designed to serve as effective and eco-friendly crop protectants. These products are specifically engineered to reduce the dependency on synthetic pesticides, addressing the critical issue of crop loss due to diseases that currently affects 20-40% of global agricultural output. Robigo’s solutions are utilized primarily by agricultural producers and growers across various regions, contributing to healthier soils and more resilient crops. Their products are marketed in key agricultural hubs, including North America, Europe, and parts of Asia, where there is a significant need for sustainable agricultural practices.

Robigo generates revenue through direct sales of its microbial products to agricultural producers and through strategic partnerships with agricultural distributors and retailers. The transaction structure is primarily B2B, with sales agreements tailored to the specific needs of clients, which may include bulk purchasing arrangements or bundled services offering comprehensive crop protection solutions. The revenue model is supported by ongoing investments, which facilitates the development and scalability of their proprietary products. These financial resources are crucial for expanding their market reach and furthering research and development initiatives in precision agriculture.

The company will use the September 2026 funding to commercial launch and expand its offerings.

## Funding rounds

- Series A, Sep 17, 2026 — Illumina Ventures, Congruent Ventures, Leaps by Bayer, Thrive by SVG Ventures, Endeavor8
- Seed, May 4, 2023, $3.1M — Aera, Supply Change Capital, Endeavor8
- Seed, Feb 10, 2023, $9.6M — First Star Ventures, Congruent Ventures, Good Growth Capital

## Investors

- First Star Ventures (https://capitalatlas.ai/funds/first-star-ventures) — Seed
- Congruent Ventures (https://capitalatlas.ai/funds/congruent-ventures) — Seed, Series A
- Good Growth Capital (https://capitalatlas.ai/funds/good-growth-capital) — Seed
- Aera (https://capitalatlas.ai/funds/aera) — Seed
- Supply Change Capital (https://capitalatlas.ai/funds/supply-change-capital) — Seed
- Endeavor8 (https://capitalatlas.ai/funds/endeavor8) — Seed, Series A
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Series A
- Leaps by Bayer (https://capitalatlas.ai/funds/leaps-by-bayer) — Series A
- Thrive by SVG Ventures — Series A